Murae Organisor Ltd
Incorporated in 2012, Murae Organisor Ltd
is in the business of pharma commodities
trading[1]
- Market Cap ₹ 190 Cr.
- Current Price ₹ 1.02
- High / Low ₹ 1.37 / 0.53
- Stock P/E 25.2
- Book Value ₹ 1.12
- Dividend Yield 0.00 %
- ROCE 4.21 %
- ROE 5.69 %
- Face Value ₹ 1.00
Pros
- Stock is trading at 0.91 times its book value
- Company has delivered good profit growth of 32.8% CAGR over last 5 years
- Debtor days have improved from 623 to 108 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.10% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 9 | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 3 | 855 | |
0 | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 25 | 13 | 4 | 845 | |
Operating Profit | 0 | 0 | 1 | 0 | 2 | 3 | 1 | -8 | -4 | 1 | -1 | 10 |
OPM % | 2% | 3% | 2% | 4% | 7% | 2% | -19% | -21% | 7% | -44% | 1% | |
0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 2 | 0 | |
Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 10 |
Tax % | 31% | 44% | 33% | 27% | 27% | 26% | 25% | 28% | 29% | 29% | 25% | |
0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 8 | |
EPS in Rs | 0.07 | 0.11 | 0.23 | 0.42 | 0.02 | 0.00 | 0.03 | 0.02 | 0.00 | 0.04 | ||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 58% |
5 Years: | 73% |
3 Years: | 244% |
TTM: | 33554% |
Compounded Profit Growth | |
---|---|
10 Years: | 53% |
5 Years: | 33% |
3 Years: | 50% |
TTM: | 14940% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -20% |
3 Years: | -9% |
1 Year: | 26% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 5% |
3 Years: | 5% |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6 | 6 | 12 | 12 | 49 | 186 |
Reserves | 0 | 1 | 1 | 1 | 5 | 6 | 8 | 8 | 4 | 6 | 6 | 23 |
0 | 1 | 2 | 2 | 7 | 10 | 9 | 11 | 9 | 9 | 0 | 213 | |
0 | 3 | 6 | 7 | 7 | 8 | 12 | 2 | 3 | 1 | 64 | 231 | |
Total Liabilities | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
0 | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 | 652 | |
Total Assets | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | -2 | -0 | 0 | -7 | -0 | -3 | -7 | 3 | 0 | -16 | -323 | |
0 | -0 | -0 | -0 | -0 | -0 | -3 | 3 | 0 | 0 | -0 | -0 | |
0 | 2 | 1 | -0 | 7 | 1 | 7 | 3 | -3 | -0 | 28 | 358 | |
Net Cash Flow | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -1 | -0 | -0 | 12 | 35 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 125 | 87 | 56 | 111 | 78 | 112 | 95 | 261 | 217 | 1,543 | 108 | |
Inventory Days | 71 | 78 | 108 | 91 | 86 | 97 | 122 | 179 | 392 | 1,439 | 1 | |
Days Payable | 113 | 107 | 83 | 77 | 54 | 83 | 10 | 18 | -25 | 7 | 85 | |
Cash Conversion Cycle | 82 | 58 | 82 | 125 | 111 | 126 | 207 | 422 | 635 | 2,975 | 24 | |
Working Capital Days | 81 | 54 | 58 | 116 | 98 | 126 | 222 | 431 | 698 | 6,342 | 160 | |
ROCE % | 0% | 22% | 21% | 22% | 25% | 24% | 17% | 4% | 12% | 12% | 1% | 4% |
Documents
Announcements
- Closure of Trading Window 2d
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 23 Jun
-
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E, 23-06-2025
23 Jun - Board approved capital increase to Rs.205 Cr, postal ballot for bonus shares 1:10 and MoA alteration.
-
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
21 Jun - Postal ballot for 1:10 bonus shares issue capitalising ₹18.59 crore; e-voting from June 24 to July 23, 2025.
-
Board Meeting Outcome for Outcome Of Meeting Of Board Of Director Of The Company Held Today I.E, June 18Th 2025
18 Jun - Board recommends 1:10 bonus shares issue, increasing paid-up capital to 204.5 crore shares.
Business Overview:[1][2][3]
a) MOL is in the business of manufacturing Pharmaceutical, Nutraceutical, Ayurvedic
Herbal products, and trading of pharma
products.
b) It acts as a commission agent in pharma products etc.
c) It provides premium cattle feed which is formulated to support livestock health and performance, while its fertilizers and chemicals are designed to optimize crop yields and ensure safety.
d) It also offers expertise in the gold sector, providing insights and services related to this precious metal